Fig. 2From: Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinomaNine representative patients with HCC underwent 18F-FDG & 18F-FAPI PET/CT imaging. 18F-FAPI PET/CT outperformed.18F-FDG PET/CT in detecting primary tumors (Patient No. 32, 33, 34, 49), intrahepatic subfoci (Patient No. 13, 38, 42, 47, 48), supraclavicular lymph node metastases (Patient No. 13, 48), retroperitoneum lymph node metastases (Patient No. 48), and comparable in detecting distant metastases (Patient No. 48)Back to article page